RT Journal Article
SR Electronic
T1 GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004704
DO 10.1136/jitc-2022-004704
VO 10
IS 12
A1 Pascual-Pasto, Guillem
A1 McIntyre, Brendan
A1 Shraim, Rawan
A1 Buongervino, Samantha N
A1 Erbe, Amy K
A1 Zhelev, Doncho V
A1 Sadirova, Shakhnozakhon
A1 Giudice, Anna M
A1 Martinez, Daniel
A1 Garcia-Gerique, Laura
A1 Dimitrov, Dimiter S
A1 Sondel, Paul M
A1 Bosse, Kristopher R
YR 2022
UL http://jitc.bmj.com/content/10/12/e004704.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.